Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
08/2007
08/30/2007US20070203218 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide
08/30/2007US20070203207 Heteroaromatic glucokinase activators
08/30/2007US20070203072 Hcv Ns-3 Serine Protease Inhibitors
08/30/2007CA2637615A1 Selective n-sulfonylation of 2-amino trifluoroalkyl substituted alcohols
08/29/2007EP1824837A1 Substituted n-sulfonylaminobenzyl-2-phenoxy acetamide compounds
08/29/2007EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
08/29/2007EP1506167B1 Hydroxy tetrahydro-naphthalenylurea derivatives
08/28/2007US7262318 Substituted heteroaryl- and phenylsulfamoyl compounds
08/28/2007US7262208 Hydroxypropyl amides for the treatment of Alzheimer's disease
08/28/2007CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
08/23/2007WO2007063028A3 Method for producing sulfonamides
08/23/2007WO2007010356A3 Process for the preparation of sulfonamide derivatives
08/23/2007US20070197828 Method of preparing optically pure phenethylamine derivatives
08/23/2007US20070197823 preparation using 2-trifluoroacetamido-3-substituted propiophenone compounds; to treat bacterial infections, nephritic syndromes, and sexually transmitted diseases; Friedel Crafts acylation; useful for making fenicol antibiotics like D-(threo)-1-p-methylsulfonylphenyl-2-dichloroacetamido-1-propanol
08/23/2007US20070197522 Dpp-iv inhibitors
08/22/2007EP1820795A1 Novel anthranilic acid derivative or salt thereof
08/22/2007EP1819668A2 Novel 2-cyano-3-(halo)alkoxy-benzenesulfonamide compounds for combating animal pests
08/22/2007EP1819667A1 Sulfonamide compounds as cysteine protease inhibitors
08/22/2007CN1332942C Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
08/21/2007US7259277 Cytosolic phospholipase A2 (cPLA2); chemical intermediates such as N-But-3-ynyl-1-(3,4-dichlorophenyl)methanesulfonamide; reacting by a substituted benzylsulfonyl chloride with an alkynylamine; end drugs are 2-sulfamido(alkyl) indoles
08/21/2007US7259187 Tropolone derivatives
08/21/2007CA2304965C ((cyclo)alkyl substituted)-gamma-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
08/16/2007WO2007091817A1 Anion receptor, and electrolyte using the same
08/16/2007WO2007091046A1 Chemical compounds
08/16/2007WO2006084688A8 HIV protease inhibitors
08/16/2007WO2003031404A3 Processes for the preparation of substituted isoxazoles and 2-isoxazolines
08/16/2007US20070190662 Acoustic sensors and methods
08/15/2007CN1331862C Di-aryl acid derivatives as PPAR receptor ligands
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
08/15/2007CN101016260A Chirality sulfonamide aminol ligand based on prolinol, its preparing method and application
08/14/2007US7256297 Methods of preparing sulfinamides and sulfoxides
08/14/2007US7256192 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
08/14/2007CA2213714C Phenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
08/09/2007WO2007089069A1 Phenyl imidazol sulfonamide derivatives, the preparation method thereof and the whitening cosmetic composition containing the same
08/09/2007WO2007087949A2 Oxonium and sulfonium salts
08/09/2007US20070185217 Propofol analogs, process for their preparation, and methods of use
08/09/2007US20070185136 Sulphonamide derivatives, their preparation and their therapeutic application
08/09/2007DE102006005103A1 Oxonium- und Sulfoniumsalze Oxonium and sulfonium salts
08/09/2007CA2641288A1 Oxonium and sulfonium salts
08/08/2007EP1708992B1 Sulfonamide derivatives for the treatment of diseases
08/08/2007CN1330632C 2,5-substituted benzoluslfonylureas and thioureas, methods for production thereof, use thereof and pharamceutical preparations containing the same
08/08/2007CN1330630C Sultonyl (thio)urea derivants, their preparation process and pharmaceutical composition containing them
08/08/2007CN101014564A Substituted acids for the treatment of respiratory diseases
08/08/2007CN101012187A Chiral diene ligand, synthesis method and its application in asymmetric reaction
08/07/2007US7253317 Method for fluorinating a compound comprising a halosulphonyl or dihalophosphonyl group
08/07/2007US7253282 Hexafluoroisopropanol substituted cyclohexane derivatives
08/07/2007US7253171 Antiinflammatory agents; immunology diseases; multiple sclerosis; antihistamines; antidiabetic agents; vision defects; antiarthritic agents; skin disorders; antitumor agents
08/07/2007CA2333938C New 3-aryl-2-hydroxypropionic acid derivative (i)
08/02/2007WO2007085718A1 Sulfonamide derivatives, preparation thereof and therapeutic use thereof
08/02/2007WO2007060220A3 Cyanobenzene compounds for combating animal pests
08/02/2007WO2007030761A3 Acyclic 1,4-diamines and uses thereof
08/02/2007US20070179315 of aromatic groups using transition metal catalysis in compressed carbon dioxide; intermediates
08/02/2007US20070179192 Thrombopoietin mimetics
08/01/2007EP1812384A1 Sulphonylated diphenylethylenediamines, method for their preparation and use in transfer hydrogenation catalysis
08/01/2007EP1812008A1 Il-8 receptor antagonists
08/01/2007EP1461038B1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/01/2007EP1377542B1 Hiv protease inhibitors based on amino acid derivatives
08/01/2007EP1018879B1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonist compounds, compositions and their uses
08/01/2007CN1329359C Ether compounds, compositions, and uses thereof
07/2007
07/31/2007US7250526 Transfer hydrogenation process and catalyst
07/31/2007US7250447 Acylsulfamide inhibitors of factor VIIa
07/31/2007US7250444 Pyrrole-based HMG-CoA reductase inhibitors
07/26/2007US20070173548 Malonamic acids and derivatives thereof as thyroid receptor ligands
07/26/2007US20070173498 Melanin concentrating hormone antagonist
07/26/2007US20070173149 Exhibit water- and oil-repellency comparable to fluoroacrylates with longer perfluorinated chains. less bioaccumulative in living organisms;acrylic polymer having a monomer of the reaction product of hydroxyalkylacrylate and diisocyante and a short-chain fluoroalkylsuloamido- alkanoic vinyl ester
07/26/2007US20070172978 Manufacture of a polymer device
07/25/2007EP1810965A1 Hydrazide derivatives
07/25/2007EP1809619A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use
07/25/2007EP1809597A1 Aminoethylaromatic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
07/25/2007EP1390340A4 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
07/25/2007EP1339655B1 Transfer hydrogenation process and catalyst
07/25/2007EP1177187B1 Di-aryl acid derivatives as ppar receptor ligands
07/25/2007CN1328254C Metal bis-triflimide compounds and methods for synthesis of metal bis-triflimide compounds
07/25/2007CN1328253C Fumaric acid ibutilide synthesis method
07/25/2007CN1328252C Novel optical pure water soluble diamine and derivative, preparation method and use thereof
07/25/2007CN1328249C Preparation process of (R)-(-)-5-(2-aminopropyl)-2-methoxyl benzene sulfonamide
07/25/2007CN101006048A Process for the synthesis c-2, c-3 substituted n-alkylated indoles useful as CPLA2 inhibitors
07/25/2007CN101006042A Chemical compounds
07/25/2007CN101003499A Novel color former and recording material
07/24/2007US7247748 E.g., 2-(3-{3-[(2-chloro-3-(trifluoromethyl)-benzyl)-(2,2-diphenylethyl)-amino]-propoxy}phenyl)-1-morpholin-4-yl-ethanone; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and reverse cholesterol transport
07/19/2007WO2007079930A1 Substituted cyclohexylmethyl derivatives
07/19/2007WO2007009083A3 Compounds with activity at retinoic acid receptors
07/19/2007US20070167635 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders
07/19/2007CA2634567A1 Substituted cyclohexylmethyl derivatives
07/18/2007EP1807392A1 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 recptor
07/18/2007EP1807391A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
07/18/2007CN101001834A Nonpeptide inhibitors of matrix metalloproteinases
07/17/2007US7244766 Sulfonamide derivatives for the treatment of diseases
07/17/2007US7244764 Methods and compositions for treating amyloid-related diseases
07/17/2007US7244755 Hydroxypropylamines
07/17/2007US7244725 treatment of Alzheimer's disease and more specifically compounds that are capable of inhibiting beta-secretase
07/17/2007CA2432643C 3-ox(adi)azolylpropanohydroxamic acids useful as procollagen c-proteinase inhibitors
07/12/2007WO2007061637A3 Fluorinated gemini surfactants
07/12/2007WO2006074957A9 Substituted aminomethylene sulphonamides, production and use thereof as medicaments
07/12/2007US20070161709 Amorphous tamsulosin hydrochloride
07/12/2007US20070161622 Diamino alcohols and their use as renin inhibitor
07/12/2007US20070161574 Hcv ns-3 serine protease inhibitors
07/11/2007EP1805138A1 Sulfonamido compounds that antagonise the vanilloid trpv1 receptor
07/11/2007EP1805136A1 Substituted phenylalkanoic acids
07/11/2007EP1805129A1 (biphenyl) carboxylic acids and derivatives thereof
1 ... 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 177